Timmerman R. Paulus R. Galvin J. et al.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

JAMA. 2010; 303: 1070-1076https://doi.org/10.1001/jama.2010.261View in Article Scopus (1702) PubMed Crossref Google ScholarOnishi H. Shirato H. Nagata Y. et al.

Stereotactic body radiotherapy (SBRT) for operable Stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?.

Int J Radiat Oncol Biol Phys. 2011; 81: 1352-1358https://doi.org/10.1016/j.ijrobp.2009.07.1751View in Article Scopus (439) PubMed Abstract Full Text Full Text PDF Google ScholarKestin L. Grills I. Guckenberger M. et al.

Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.

Radiother Oncol. 2014; 110: 499-504https://doi.org/10.1016/j.radonc.2014.02.002View in Article Scopus (98) PubMed Abstract Full Text Full Text PDF Google ScholarStephans K.L. Woody N.M. Reddy C.A. et al.

Tumor control and toxicity for common stereotactic body radiation therapy dose-fractionation regimens in Stage I non-small cell lung cancer.

Int J Radiat Oncol Biol Phys. 2018; 100: 462-469https://doi.org/10.1016/j.ijrobp.2017.10.037View in Article Scopus (34) PubMed Abstract Full Text Full Text PDF Google ScholarShah J.L. Loo B.W.

Stereotactic ablative radiotherapy for early-stage lung cancer.

Semin Radiat Oncol. 2017; 27: 218-228https://doi.org/10.1016/j.semradonc.2017.03.001View in Article Scopus (13) PubMed Crossref Google ScholarTimmerman R. McGarry R. Yiannoutsos C. et al.

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

J Clin Oncol. 2006; 24: 4833-4839https://doi.org/10.1200/JCO.2006.07.5937View in Article Scopus (1063) PubMed Crossref Google ScholarNuyttens J.J. Van Der Voort Van Zyp N.C. Praag J. et al.

Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.

Radiother Oncol. 2012; 102: 383-387https://doi.org/10.1016/j.radonc.2011.12.023View in Article Scopus (86) PubMed Abstract Full Text Full Text PDF Google ScholarChang J.Y. Li Q.Q. Xu Q.Y. et al.

Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a “no fly zone.

Int J Radiat Oncol Biol Phys. 2014; 88: 1120-1128https://doi.org/10.1016/j.ijrobp.2014.01.022View in Article Scopus (148) PubMed Abstract Full Text Full Text PDF Google ScholarChang J.Y. Bezjak A. Mornex F.

Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: What we have learned.

J Thorac Oncol. 2015; 10: 577-585https://doi.org/10.1097/JTO.0000000000000453View in Article Scopus (82) PubMed Abstract Full Text Full Text PDF Google ScholarHaseltine J.M. Rimner A. Gelblum D.Y. et al.

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.

Pract Radiat Oncol. 2016; 6: e27-e33https://doi.org/10.1016/j.prro.2015.09.012View in Article Scopus (75) PubMed Abstract Full Text Full Text PDF Google ScholarTekatli H. Haasbeek N. Dahele M. et al.

Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with “ultracentral” non-small cell lung cancer.

J Thorac Oncol. 2016; 11: 1081-1089https://doi.org/10.1016/j.jtho.2016.03.008View in Article Scopus (99) PubMed Abstract Full Text Full Text PDF Google ScholarVidetic G.M. Donington J. Giuliani M. et al.

Stereotactic body radiation therapy for early stage non-small cell lung cancer: An ASTRO evidence-based guideline.

Pract Radiat Oncol. 2017; 7: 295-301View in Article Scopus (0) PubMed Abstract Full Text Full Text PDF Google ScholarZhao Y. Khawandanh E. Thomas S. et al.

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors.

Radiat Oncol. 2020; 15: 1-13https://doi.org/10.1186/s13014-020-01491-wView in Article Scopus (5) Crossref Google ScholarRaman S. Yau V. Pineda S. et al.

Ultracentral tumors treated with stereotactic body radiotherapy: Single-institution experience.

Clin Lung Cancer. 2018; 19: e803-e810https://doi.org/10.1016/j.cllc.2018.06.001View in Article Scopus (25) PubMed Abstract Full Text Full Text PDF Google ScholarMurrell D.H. Laba J.M. Erickson A. et al.

Stereotactic ablative radiotherapy for ultra-central lung tumors: Prioritize target coverage or organs at risk?.

Radiat Oncol. 2018; 13 (2018 131): 57https://doi.org/10.1186/s13014-018-1001-6View in Article Scopus (18) PubMed Crossref Google ScholarRoesch J. Panje C. Sterzing F. et al.

SBRT for centrally localized NSCLC - What is too central?.

Radiat Oncol. 2016; 11: 1-9https://doi.org/10.1186/s13014-016-0732-5View in Article Scopus (20) PubMed Crossref Google ScholarKron T.

Reduction of margins in external beam radiotherapy.

J Med Phys. 2008; : 41-42https://doi.org/10.4103/0971-6203.41190View in Article Scopus (6) PubMed Crossref Google ScholarOhri N. Werner-Wasik M. Grills I.S. et al.

Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: A report from the Elekta Collaborative Lung Research Group.

Int J Radiat Oncol Biol Phys. 2012; 84https://doi.org/10.1016/j.ijrobp.2012.04.040View in Article Scopus (39) Abstract Full Text Full Text PDF Google ScholarGay H.A. Niemierko A.

A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.

Phys Medica. 2007; 23: 115-125https://doi.org/10.1016/j.ejmp.2007.07.001View in Article Scopus (180) PubMed Abstract Full Text Full Text PDF Google ScholarMartel M.K. Ten Haken R.K. Hazuka M.B. et al.

Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.

Lung Cancer. 1999; 24: 31-37View in Article Scopus (275) PubMed Abstract Full Text Full Text PDF Google ScholarDuijm M. Tekatli H. Oomen-de Hoop E. et al.

Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.

Radiother Oncol. 2018; 127: 233-238https://doi.org/10.1016/j.radonc.2018.02.004View in Article Scopus (5) PubMed Abstract Full Text Full Text PDF Google ScholarChen S.W. Liang J.A. Hung Y.C. et al.

Geometrical sparing factors for the rectum and bladder in the prediction of Grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.

Int J Radiat Oncol Biol Phys. 2009; 75: 1335-1343https://doi.org/10.1016/j.ijrobp.2008.12.018View in Article Scopus (6) PubMed Abstract Full Text Full Text PDF Google ScholarJones B. Dale R.G.

Mathematical models of tumour and normal tissue response.

Acta Oncol (Madr). 1999; 38: 883-893https://doi.org/10.1080/028418699432572View in Article Scopus (86) PubMed Crossref Google ScholarCannon D.M. Mehta M.P. Adkison J.B. et al.

Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.

J Clin Oncol. 2013; https://doi.org/10.1200/JCO.2013.51.5353View in Article Scopus (98) Crossref Google ScholarPollom E.L. Chin A.L. Diehn M. et al.

Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy.

Semin Radiat Oncol. 2017; 27: 197-208https://doi.org/10.1016/j.semradonc.2017.02.001View in Article Scopus (21) PubMed Crossref Google ScholarKang K.H. Okoye C.C. Patel R.B. et al.

Complications from stereotactic body radiotherapy for lung cancer.

Cancers (Basel). 2015; 7: 981-1004https://doi.org/10.3390/cancers7020820View in Article Scopus (54) PubMed Crossref Google ScholarGholami S. Nedaie H. Longo F. et al.

Grid block design based on monte carlo simulated dosimetry, the linear quadratic and Hug-Kellerer radiobiological models.

J Med Phys. 2017; 42: 213-221https://doi.org/10.4103/jmp.JMP_38_17View in Article Scopus (10) PubMed Crossref Google ScholarChen S.W. Liang J.A. Hung Y.C. et al.

Does initial 45gy of pelvic intensity-modulated radiotherapy reduce late complications in patients with locally advanced cervical cancer? A cohort control study using definitive chemoradiotherapy with high-dose rate brachytherapy.

Radiol Oncol. 2013; 47: 176-184https://doi.org/10.2478/raon-2013-0011View in Article Scopus (13) PubMed Crossref Google ScholarPalma B.D. Daly M. Urbanic J. et al.

Stereotactic radiation for ultra-central lung tumors : Good idea, or ultra-risky ?.

Radiat Oncol Biol. 2018; 103: 788-791https://doi.org/10.1016/j.ijrobp.2018.10.008